TECENTRIQ HYBREZA Trademark

Trademark Overview


On Thursday, May 18, 2023, a trademark application was filed for TECENTRIQ HYBREZA with the United States Patent and Trademark Office. The USPTO has given the TECENTRIQ HYBREZA trademark a serial number of 98002465. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, August 6, 2024. This trademark is owned by Genentech, Inc.. The TECENTRIQ HYBREZA trademark is filed in the Education & Entertainment Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Education services, namely, providing courses, presentations, and training for patients and medical professionals, in the field of oncology, autoimmune, and inflammatory diseases and disorders; Providing online non-downloadable electronic publications in the nature of brochures in the field of oncology, autoimmune and inflammatory diseases and disorders

Providing medical information in the field of oncology, autoimmune, and inflammatory diseases and disorders
tecentriq hybreza

General Information


Serial Number98002465
Word MarkTECENTRIQ HYBREZA
Filing DateThursday, May 18, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, August 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 11, 2024

Trademark Statements


Goods and ServicesEducation services, namely, providing courses, presentations, and training for patients and medical professionals, in the field of oncology, autoimmune, and inflammatory diseases and disorders; Providing online non-downloadable electronic publications in the nature of brochures in the field of oncology, autoimmune and inflammatory diseases and disorders
Description of MarkThe mark consists of the word "TECENTRIQ" written in a stylized font with the word "HYBREZA" written in a stylized font under it. The first "T" in the word "TECENTRIQ" has three arrows pointing inwards in a circle above it in the upper left hand corner.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesProviding medical information in the field of oncology, autoimmune, and inflammatory diseases and disorders

Classification Information


International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateTuesday, June 20, 2023
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, June 20, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGenentech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameGenentech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Monday, May 22, 2023NEW APPLICATION ENTERED
Wednesday, June 21, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, June 20, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 7, 2024ASSIGNED TO EXAMINER
Thursday, February 8, 2024NON-FINAL ACTION WRITTEN
Thursday, February 8, 2024NON-FINAL ACTION E-MAILED
Thursday, February 8, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 8, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 8, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 22, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 11, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 11, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 6, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT